close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Tags Business Companies Pharmaceuticals
From CNBC.com News
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
Tags Health & Science Biotechnology US: News
From CNBC.com News
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
Tags LILLY DRN Novo Nordisk A/S Health care industry
From CNBC.com News
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
Tags Elevance Health Inc Social issues Centene Corp
From CNBC.com News
5 European stocks to watch this earnings season as Trump's tariffs hit
Tickers OIL
Tags Energy Oil and Gas Pharmaceuticals
From CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
Tags Companies Business Roche Holding AG
From CNBC.com News
CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine
Tags UBS Group AG Novo Nordisk A/S NVIDIA Corp
From CNBC.com News
Pfizer scraps daily weight loss pill after liver injury in one patient
Tags Breaking News: Business Pfizer Inc Health & Science
From CNBC.com News
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback
Tags Consumer Goods Politics Breaking News: Politics
From CNBC.com News
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
Tags LILLY DRN Novo Nordisk A/S Health care industry
From CNBC.com News
The biggest winners and losers in Europe as Trump announces sweeping tariffs
Tags Novo Nordisk A/S U/S/ Economy Brunello Cucinelli SpA
From CNBC.com News
Pharma tariff relief likely short-lived with sector-specific duties on the horizon
Tags AstraZeneca PLC Novartis AG Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
Tags US: News Biotechnology Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
Tags Biotech and Pharmaceuticals Biotechnology LILLY DRN
From CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Tags Novo Nordisk A/S Pharmaceuticals LILLY DRN
From CNBC.com News
CNBC Daily Open: Consumers and CFOs alike are expecting a recession in the U.S.
Tags Tesla Inc Microstrategy Inc Novo Nordisk A/S
From CNBC.com News
CNBC Daily Open: Fears of a U.S. recession intensify among consumers and CFOs
Tags Market Outlook World Markets Asia Markets
From CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
Tags Health & Science Biotech and Pharmaceuticals LILLY DRN
From CNBC.com News
Software giant SAP becomes Europe's most valuable firm amid German stock market boom
Tags Novo Nordisk A/S Europe Markets Breaking News: Markets
From CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Tags Companies Business Roche Holding AG
From CNBC.com News
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
Tags LILLY DRN Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Zepbound copycats remain online despite FDA ban
Tags Business Retail industry Pharmaceuticals
From CNBC.com News
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests
Tags Healthy Returns Dexcom Inc Biotech and Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Novo Nordisk A/S Economy Business News
From CNBC.com News
Novo Nordisk shares fall 5.5% after latest trial results for its next-generation weight loss drug
Tags Novo Nordisk A/S Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Amgen starts two critical late-stage trials for weight loss drug MariTide
Tags Novo Nordisk A/S Science Health care industry
From CNBC.com News
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
Tags Companies Business Pharmaceuticals
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Health care industry Science Salesforce Inc
From CNBC.com News
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
Tags LILLY DRN Health care industry Business News
From CNBC.com News
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
Tags LILLY DRN Novo Nordisk A/S Health care industry
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today